Centene マネジメント

マネジメント基準チェック /14

Centeneの CEO はSarah Londonで、 Mar2022年に任命され、の在任期間は 2.67年です。の年間総報酬は$ 18.56Mで、 7.5%給与と92.5%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の0.035%を直接所有しており、その価値は$ 10.78M 。経営陣と取締役会の平均在任期間はそれぞれ3.5年と2.8年です。

主要情報

Sarah London

最高経営責任者

US$18.6m

報酬総額

CEO給与比率	7.5%
CEO在任期間	2.7yrs
CEOの所有権	0.04%
経営陣の平均在職期間	3.5yrs
取締役会の平均在任期間	2.8yrs

経営陣の近況

Recent updates

CEO報酬分析

Centene の収益と比較して、Sarah London の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Sep 30 2024	n/a	n/a	US$3b
Jun 30 2024	n/a	n/a	US$3b
Mar 31 2024	n/a	n/a	US$3b
Dec 31 2023	US$19m	US$1m	US$3b
Sep 30 2023	n/a	n/a	US$2b
Jun 30 2023	n/a	n/a	US$3b
Mar 31 2023	n/a	n/a	US$1b
Dec 31 2022	US$13m	US$1m	US$1b
Sep 30 2022	n/a	n/a	US$2b
Jun 30 2022	n/a	n/a	US$2b
Mar 31 2022	n/a	n/a	US$1b
Dec 31 2021	US$15m	US$978k	US$1b

報酬と市場: Sarahの総報酬 ($USD 18.56M ) は、 UK市場 ($USD 5.66M ) の同規模の企業の平均を上回っています。

報酬と収益: Sarahの報酬は過去 1 年間で 20% 以上増加しました。

CEO（最高経営責任者

Sarah London (43 yo)

2.7yrs

在職期間

US$18,556,966

報酬

Ms. Sarah M. London has been the Chief Executive Officer of Centene Corporation since March 21, 2022 and serves as its Director since September 2021. She served as President of Health Care Enterprises and...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Sarah London	CEO & Director	2.7yrs	US$18.56m	0.035% $ 10.8m
Kenneth Fasola	President	1.9yrs	US$10.62m	0.016% $ 4.8m
Andrew Asher	Executive VP & CFO	3.5yrs	US$9.91m	0.046% $ 14.2m
Christopher Koster	Executive VP	4.8yrs	US$4.84m	0.019% $ 5.9m
David Thomas	CEO of Markets & Medicaid	5.8yrs	US$6.20m	0.0094% $ 2.9m
Susan Smith	Chief Operating Officer	less than a year	データなし	0.0022% $ 676.6k
Katie Casso	Senior VP	3.6yrs	データなし	0.0056% $ 1.7m
Brian LeClaire	Chief Information Officer	1.9yrs	データなし	データなし
Jennifer Gilligan	Senior Vice President of Investor Relations	4.6yrs	データなし	データなし
Ashlee Knuckey	Chief Risk	2.2yrs	データなし	データなし
Suzy DePrizio	Senior VP & Chief Marketing Officer	3.5yrs	データなし	データなし
H. Sanders	Executive Vice President of Global Human Resources	3.7yrs	データなし	データなし

3.5yrs

平均在職期間

56.5yo

平均年齢

経験豊富な経営陣: 0HVBの経営陣は経験豊富であると考えられます ( 3.5年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Sarah London	CEO & Director	3.2yrs	US$18.56m	0.035% $ 10.8m
Monte Ford	Independent Director	2yrs	US$324.98k	0.00086% $ 262.1k
Frederick Eppinger	Independent Chairman	18.6yrs	US$537.45k	0.069% $ 20.9m
Christopher Coughlin	Independent Director	2.8yrs	US$369.98k	0.0046% $ 1.4m
H. Dallas	Lead Independent Director	4.8yrs	US$474.98k	0.0074% $ 2.3m
Wayne DeVeydt	Independent Director	2.8yrs	US$372.48k	0.0022% $ 685.8k
Thomas Greco	Director	less than a year	データなし	データなし
Theodore Samuels	Independent Director	2.8yrs	US$349.98k	0.0057% $ 1.7m
Kenneth Burdick	Director	2.8yrs	US$1.25m	0.088% $ 26.9m
Jessica Blume	Independent Director	6.8yrs	US$344.98k	0.0043% $ 1.3m
Lori Robinson	Independent Director	5.1yrs	US$299.98k	0.0023% $ 691.9k

2.8yrs

平均在職期間

65yo

平均年齢

経験豊富なボード: 0HVBの取締役会は経験豊富ではない ( 2.8年の平均在任期間) ため、新しい取締役会が必要であると考えられます。

Centene マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

Executive VP & CFO recently bought US$1.0m worth of stock

Centene Corporation Announces the Election of Thomas R. Greco to Board of Directors

Centene Corporation, Annual General Meeting, May 14, 2024

Centene Corporation Announces Appointment of Michael A. Carson as President and Chief Executive Officer of Its Medicare Business

Centene Corporation Announces the Appointment of Susan Smith as Chief Operating Officer, Effective January 1, 2024

Centene Corporation Names Wade Rakes as Chief Growth Officer

Recent updates

Executive VP & CFO recently bought US$1.0m worth of stock

Centene Corporation Provides Earnings Guidance for the Year 2024

Third quarter 2024 earnings released: EPS: US$1.37 (vs US$0.87 in 3Q 2023)

Investor sentiment deteriorates as stock falls 16%

Centene Corporation to Report Q3, 2024 Results on Oct 25, 2024

Ambetter Health of Delaware Offers Health Insurance in Delaware in 2025

Ambetter from Coordinated Care Offers Health Insurance Statewide in Washington in 2025

Centene Corporation Announces the Election of Thomas R. Greco to Board of Directors

Second quarter 2024 earnings released: EPS: US$2.16 (vs US$1.93 in 2Q 2023)

Centene Corporation to Report Q2, 2024 Results on Jul 26, 2024

Centene Corporation Updates Earnings Guidance for the Year 2024

First quarter 2024 earnings released: EPS: US$2.17 (vs US$2.05 in 1Q 2023)

Centene Corporation, Annual General Meeting, May 14, 2024

Centene Corporation to Report Q1, 2024 Results on Apr 26, 2024

Full year 2023 earnings released: EPS: US$4.97 (vs US$2.09 in FY 2022)

Centene Corporation Increases Premium and Service Revenues Guidance for the Fiscal Year 2024

Centene Corporation Announces Appointment of Michael A. Carson as President and Chief Executive Officer of Its Medicare Business

Pure Health LLC completed the acquisition of Circle Health Group Limited from Centene Corporation (NYSE:CNC).

Centene Corporation to Report Fiscal Year 2023 Results on Feb 06, 2024

Centene Corporation Provides Earnings Guidance for the Fiscal Year 2024

Centene Corporation Announces the Appointment of Susan Smith as Chief Operating Officer, Effective January 1, 2024

Third quarter 2023 earnings released: EPS: US$0.87 (vs US$1.29 in 3Q 2022)

Centene Corporation Provides Earnings Guidance for the Full Year 2023

Centene Corporation Names Wade Rakes as Chief Growth Officer

Centene Corporation to Report Q3, 2023 Results on Oct 24, 2023

Pure Health LLC agreed to acquire Circle Health Group Limited from Centene Corporation (NYSE:CNC) for an enterprise value of approximately $1.2 billion.

Centene Corporation Provides Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings released: EPS: US$1.93 (vs US$0.29 loss in 2Q 2022)

Centene Corporation to Report Q2, 2023 Results on Jul 28, 2023

New Mountain Capital, L.L.C. acquired Apixio, Inc. from Centene Corporation.

Centene Corporation Appoints T. Susko as Its Senior Vice President and Chief Communications Officer

Centene Corporation Announces Resignation of James E. Murray as Chief Operating Officer

New Mountain Capital, L.L.C. agreed to acquire Apixio, Inc. from Centene Corporation (NYSE : CNC).

Centene to Divest AI Platform Apixio

First quarter 2023 earnings released: EPS: US$2.05 (vs US$1.46 in 1Q 2022)

CEO & Director recently bought US$1.9m worth of stock

Independent Director recently bought US$503k worth of stock

Centene Corporation Provides Earnings Guidance for the Full Year 2023

Full year 2022 earnings released: EPS: US$2.09 (vs US$2.31 in FY 2021)

Centene Corporation to Report Fiscal Year 2022 Results on Feb 07, 2023

Centene Corporation Announces Management Changes

Vivalto Santé SA completed the acquisition of Torrejon Salud, S.A. from Centene Corporation (NYSE:CNC).

Vivalto Santé SA completed the acquisition of Ribera Salud, S.A from Centene Corporation (NYSE:CNC).

Centene Corporation Appoints Monte Ford to Board of Directors

High number of new directors

Centene Corporation Provides Earnings Guidance for the Full Year 2022

Centene Corporation to Report Q3, 2022 Results on Oct 25, 2022

Centene Corporation Appoints Ashlee Knuckey as Chief Ethics and Compliance Officer

Centene Corporation Announces James Dallas to Step Down as Chairman of the Board

Vivalto Sante Investissement entered into agreement to acquire Ribera Salud, S.A from Centene Corporation (NYSE:CNC) on July 25, 2022.

Vivalto Santé SA agreed to acquire SPANISH AND CENTRAL EUROPEAN BUSINESSES Of CENTENE from Centene Corporation (NYSE:CNC).

A consortium of The Vistria Group, LLC, General Atlantic Service Company, L.P. and Nautic Partners, LLC completed the acquisition of PANTHERx Rare, LLC from Centene Corporation (NYSE:CNC).

Centene Corporation to Report Q2, 2022 Results on Jul 26, 2022

Centene Corporation Revises Revenue Guidance for the Fiscal Year 2022

A consortium of The Vistria Group, LLC, General Atlantic Service Company, L.P. and Nautic Partners, LLC signed a definitive agreement to acquire PANTHERx Rare, LLC from Centene Corporation (NYSE:CNC).

Independent Director recently bought US$507k worth of stock

First quarter 2022 earnings released: EPS: US$1.46 (vs US$1.20 in 1Q 2021)

High number of new directors

Centene Corporation Provides Earnings Guidance for the Full Year 2022

Centene Corporation Announces Resignation of Leslie V. Norwalk, Esq. as A Member of the Board

Centene Corporation Announces Executive Changes

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Centene Corporation Provides Earnings Guidance for the Full Year 2022

Centene Reportedly Drew Takeover Interest from Cigna in Recent Months

Centene Corporation (NYSE:CNC) completed the acquisition of Magellan Health, Inc. (NasdaqGS:MGLN) from a group of shareholders.

Centene Corporation Reaffirms earnings Guidance for 2021; Provides Earnings Guidance for 2022

Valtruis, Oak HC/FT Partners LLC, HLM Venture Partners and Founders of Rubicon completed the acquisition of an unknown majority stake in U.S. Medical Management, LLC from Centene Corporation (NYSE:CNC).

Third quarter 2021 earnings released: EPS US$1.00 (vs US$0.98 in 3Q 2020)

Independent Director David Steward has left the company

マネジメント基準チェック /14